[Corrigendum] (‑)‑Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase‑dependent pathway and Bcl‑2 family protein modulation

• Authors:
  • Jiangyan Wang
  • Yu'An Xie
  • Yan Feng
  • Litu Zhang
  • Xinping Huang
  • Xiaoyun Shen
  • Xiaoling Luo

• View Affiliations

  
  Affiliations: Research Department, Affiliated Tumour Hospital of Guangxi Medical University, Nanning 530021, P.R. China
• Published online on: August 28, 2024     https://doi.org/10.3892/ijo.2024.5683
• Article Number: 95

• Copyright : © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article

Int J Oncol 46: [Related article:] 1507-1515, 2015; DOI: 10.3892/ijo.2015.2869

Subsequently to the publication of the above article, an interested reader drew to the authors' attention that, in Fig. 3 on p. 1510, the western blot images selected to portray the caspase 7 and PARP/cleaved PARP experiments were remarkably similar.

Figure 3 EGCG increases the activation of caspase-3, -7 and PARP. (A) Jeko-1 or Raji cells were treated with EGCG at different concentrations (0, 20, 40 and 60 μg/ml) for 24 h. Equal amounts of total protein were examined by western blot analysis with indicated antibodies. β-actin was used as a loading control. Representative data from three independent experiments are shown. (B) Relative intensity of cleaved caspase-3, -7 and PARP, normalized by uncleaved caspase-3, -7 and PARP. Values represent mean ± SD from three independent experiments. *p<0.05, compared with control cells (0 μg/ml).

After having referred to their original data, the authors realized that the PARP/cleaved PARP blots had been inadvertently duplicated in the figure. The revised version of Fig. 3, showing the correct data for the caspase-7 experiment, is shown below. The authors confirm that the errors made during the assembly of Fig. 3 did not adversely affect the major conclusions presented in this paper, and are grateful to the Editor of International Journal of Oncology for allowing them this opportunity to publish a corrigendum. They also apologize to the readership for any inconvenience caused.